MICB and neoplasm: Study by Møller et al. [19] indicated that propionate metabolism can regulate the expression of NKG2D ligands MICA and MICB on tumor cells by promoting the flux of cytoplasmic citrate from mitochondria, potentially increasing the sensitivity of tumor cells to NK cell–mediated immune responses.